Christina Wang
Endocrinology, Diabetes & Metabolism · Torrance, CANPI 1225131170
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $505 of the $573 with a category attached, or 88.2%. 10 manufacturers reported payments, led by Corcept Therapeutics at 29.2% of the total. Reporting peaked in 2019 at $225 and has fallen 93.4% since, to $15 in 2025. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in CA, where the typical reported total is $1,096.
Across 23 payments — averaging $24.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$167
- Journey Medical Corporation$124
- Lilly USA, LLC$90
- AstraZeneca$56
- Pfizer$38
- Napo Pharmaceuticals Inc$25
- plus $74 from 4 others
Across 61 payments — averaging $6733.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ascendis Pharma Endocrinology Inc$337K
- Corcept Therapeutics$23K
- AstraZeneca$23K
- Amryt Pharma Holdings Ltd$15K
- Chiasma, Inc.$7K
- Pfizer$4K
- plus $2K from 1 others
What the payments were for
- Travel & lodging$6812%
- Food & beverage$50588%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 6 | $167 |
| Journey Medical Corporation | 1 | $124 |
| Lilly USA, LLC | 6 | $90 |
| AstraZeneca | 2 | $56 |
| Pfizer | 2 | $38 |
| Napo Pharmaceuticals Inc | 2 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Dexcom, Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Accutane$124
How this compares
$573 in reported general payments places this provider in the 35th percentile of 952 endocrinology, diabetes & metabolism providers in California.
See all endocrinology, diabetes & metabolism providers in California →
Other endocrinology, diabetes & metabolism in Torrance
- Juan FriasSan Diego$1.4M
- Joselito CabaccanSan Jose$1.4M
- Daniel NadeauNewport Beach$1.2M
- Yehuda HandelsmanTarzana$1M
- Helen BaronRancho Mirage$958K
- Ken FujiokaSan Diego$747K
- Minou TranPico Rivera$663K
- James ChuMonterey$639K
- Anthony HeaneyLos Angeles$588K
- Daniel Einhornla Jolla$578K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.